[Image from Exactech]Exactech announced today that the FDA granted a breakthrough device designation to JointMedica’s Polymotion hip resurfacing system.
Gainesville, Florida-based Exactech, a minority shareholder of JointMedica, collaborates with the United Kingdom-based orthopedic device designer and manufacturer on next-generation hip resurfacing and holds exclusive global distribution rights to the product.
“This designation by the FDA is a validation of our core belief at JointMedica—that our hip resurfacing device addresses an acute unmet need of relatively younger, active hip arthritis patients,” JointMedica Managing Director Terence Smith said in a news release.
Polymotion features advanced polyethylene and titanium manufacturing technology, Exactech said. It was designed to offer the biomechanical benefits of hip resurfacing while eliminating metal-on-metal articulating surfaces.
“We are thrilled that Polymotion and JointM…